Peringkat dalam Saham
#21732
MDxHealth S.A. is a commercial-stage precision diagnostics company that... MDxHealth S.A. is a commercial-stage precision diagnostics company that delivers urological solutions across the United States, the Netherlands, Belgium, Spain, Poland, Italy, the rest of the European Union, and other international markets. They offer innovative genomic testing solutions for prostate cancer, notably the non-invasive SelectMDx urine test and the epigenetic ConfirmMDx test. These advanced tools assist physicians in identifying clinically significant prostate cancer, thus minimizing the need for invasive procedures and their associated complications. Founded in 2003 as OncoMethylome Sciences SA, the company adopted its current name, MDxHealth SA, in October 2010 and is headquartered in Herstal, Belgium.
Harga Saham
$3.58
Terakhir disinkronkan: 2023-12-15
Kapitalisasi Pasar
$101.57M
Perubahan (1 tahun)
0.00%
Perdagangan MDxHealth S.A. (MDXH)
Harga MDXH dengan kapitalisasi pasar B
Kapitalisasi pasar dari MDxHealth S.A.(MDXH)
Kapitalisasi Pasar: $101.57M
Per August 2026, MDxHealth S.A. memiliki kapitalisasi pasar sebesar $101.57M. Ini menjadikan MDxHealth S.A. sebagai perusahaan 21732nd paling bernilai di dunia menurut data kami. Kapitalisasi pasar adalah nilai total saham beredar dari perusahaan publik dan biasanya digunakan untuk mengukur seberapa besar nilai sebuah perusahaan.
Riwayat kapitalisasi pasar MDxHealth S.A. dari 2006 hingga 2026
MDXH dibandingkan dengan 5 teratas stocks paling populer
| Harga MDXH |
|
Aset B |
Pasar B |
Hasil |
|
|
|
|
$5.211T
|
+5,130,713.72%
|
|
|
|
|
$4.547T
|
+4,476,364.28%
|
|
|
|
|
$4.162T
|
+4,098,034.15%
|
|
|
|
|
$3.593T
|
+3,537,154.86%
|
|
|
|
|
$2.793T
|
+2,749,583.54%
|
